Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

Similar articles for PubMed (Select 21691262)

1.

A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation.

Bisht S, Khan MA, Bekhit M, Bai H, Cornish T, Mizuma M, Rudek MA, Zhao M, Maitra A, Ray B, Lahiri D, Maitra A, Anders RA.

Lab Invest. 2011 Sep;91(9):1383-95. doi: 10.1038/labinvest.2011.86. Epub 2011 Jun 20.

3.

Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation.

Fu Y, Zheng S, Lin J, Ryerse J, Chen A.

Mol Pharmacol. 2008 Feb;73(2):399-409. Epub 2007 Nov 15.

4.

Curcumin protects against acute liver damage in the rat by inhibiting NF-kappaB, proinflammatory cytokines production and oxidative stress.

Reyes-Gordillo K, Segovia J, Shibayama M, Vergara P, Moreno MG, Muriel P.

Biochim Biophys Acta. 2007 Jun;1770(6):989-96. Epub 2007 Feb 22.

PMID:
17383825
5.

Curcumin ameliorates intrahepatic angiogenesis and capillarization of the sinusoids in carbon tetrachloride-induced rat liver fibrosis.

Yao Q, Lin Y, Li X, Shen X, Wang J, Tu C.

Toxicol Lett. 2013 Sep 12;222(1):72-82. doi: 10.1016/j.toxlet.2013.06.240. Epub 2013 Jul 8.

PMID:
23845850
6.

Alteration of AP-endonuclease1 expression in curcumin-treated fibrotic rats.

Bassiouny AR, Zaky A, Kandeel KM.

Ann Hepatol. 2011 Oct-Dec;10(4):516-30.

7.

Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation.

Borkham-Kamphorst E, Drews F, Weiskirchen R.

Liver Int. 2011 May;31(5):656-65. doi: 10.1111/j.1478-3231.2011.02495.x. Epub 2011 Mar 16.

PMID:
21457438
8.

Novel dipeptide nanoparticles for effective curcumin delivery.

Alam S, Panda JJ, Chauhan VS.

Int J Nanomedicine. 2012;7:4207-22. doi: 10.2147/IJN.S33015. Epub 2012 Aug 3.

9.

A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy.

Pramanik D, Campbell NR, Das S, Gupta S, Chenna V, Bisht S, Sysa-Shah P, Bedja D, Karikari C, Steenbergen C, Gabrielson KL, Maitra A, Maitra A.

Oncotarget. 2012 Jun;3(6):640-50.

10.

Bee venom inhibits hepatic fibrosis through suppression of pro-fibrogenic cytokine expression.

Kim SJ, Park JH, Kim KH, Lee WR, Chang YC, Park KK, Lee KG, Han SM, Yeo JH, Pak SC.

Am J Chin Med. 2010;38(5):921-35.

PMID:
20821823
11.

Curcumin inhibits collagen synthesis and hepatic stellate cell activation in-vivo and in-vitro.

Kang HC, Nan JX, Park PH, Kim JY, Lee SH, Woo SW, Zhao YZ, Park EJ, Sohn DH.

J Pharm Pharmacol. 2002 Jan;54(1):119-26.

PMID:
11829122
12.

Cooperation of liver cells in health and disease.

Kmieć Z.

Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. Review.

PMID:
11729749
13.

Overexpression of c-myc in hepatocytes promotes activation of hepatic stellate cells and facilitates the onset of liver fibrosis.

Nevzorova YA, Hu W, Cubero FJ, Haas U, Freimuth J, Tacke F, Trautwein C, Liedtke C.

Biochim Biophys Acta. 2013 Oct;1832(10):1765-75. doi: 10.1016/j.bbadis.2013.06.001. Epub 2013 Jun 12.

14.

Protective effects of curcumin against hepatic fibrosis induced by carbon tetrachloride: modulation of high-mobility group box 1, Toll-like receptor 4 and 2 expression.

Tu CT, Yao QY, Xu BL, Wang JY, Zhou CH, Zhang SC.

Food Chem Toxicol. 2012 Sep;50(9):3343-51. doi: 10.1016/j.fct.2012.05.050. Epub 2012 Jun 7.

PMID:
22683883
15.

[Prophylactic effect of curcumin on hepatic fibrosis and its relationship with activated hepatic stellate cells].

He YJ, Shu JC, Lü X, Fang L, Sheng Y.

Zhonghua Gan Zang Bing Za Zhi. 2006 May;14(5):337-40. Chinese.

PMID:
16732906
16.

Curcumin prevents and reverses cirrhosis induced by bile duct obstruction or CCl4 in rats: role of TGF-beta modulation and oxidative stress.

Reyes-Gordillo K, Segovia J, Shibayama M, Tsutsumi V, Vergara P, Moreno MG, Muriel P.

Fundam Clin Pharmacol. 2008 Aug;22(4):417-27. doi: 10.1111/j.1472-8206.2008.00611.x.

PMID:
18705752
17.

Protective effect of xanthohumol on toxin-induced liver inflammation and fibrosis.

Dorn C, Heilmann J, Hellerbrand C.

Int J Clin Exp Pathol. 2012;5(1):29-36. Epub 2012 Jan 1.

18.

Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats.

Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK.

Int J Pharm. 2007 Feb 7;330(1-2):155-63. Epub 2006 Sep 23.

PMID:
17112692
19.

A novel synthetic mono-carbonyl analogue of curcumin, A13, exhibits anti-inflammatory effects in vivo by inhibition of inflammatory mediators.

Wang Y, Yu C, Pan Y, Yang X, Huang Y, Feng Z, Li X, Yang S, Liang G.

Inflammation. 2012 Apr;35(2):594-604. doi: 10.1007/s10753-011-9350-4.

PMID:
21614553
20.

Nicotinamide induces apoptosis and reduces collagen I and pro-inflammatory cytokines expression in rat hepatic stellate cells.

Traister A, Breitman I, Bar-Lev E, Zvibel I, Harel A, Halpern Z, Oren R.

Scand J Gastroenterol. 2005 Oct;40(10):1226-34.

PMID:
16165703
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk